Response of Hepatitis C Genotype-4 Naïve Patients to 24 Weeks of Peg-Interferon-α2b/Ribavirin or Induction-Dose Interferon-α2b/Ribavirin/Amantadine: A Non-Randomized Controlled Study
2005
Response of Hepatitis C Genotype-4 Naive Patients to 24 Weeks of Peg-Interferon-α2b/Ribavirin or Induction-Dose Interferon-α2b/Ribavirin/Amantadine: A Non-Randomized Controlled Study
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
78
Citations
NaN
KQI